» Articles » PMID: 39458631

Utilizing an Ex Vivo Skin Penetration Analysis Model for Predicting Ocular Drug Penetration: A Feasibility Study with Curcumin Formulations

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2024 Oct 26
PMID 39458631
Authors
Affiliations
Soon will be listed here.
Abstract

Methods: Several formulation principles were explored, including oily solutions, oily suspensions, aqueous nanosuspension, micelles, liposomes and cyclodextrins. The dermal penetration efficacy was tested using an ex vivo porcine ear model previously developed at Philipps-Universität Marburg with subsequent digital image processing. This image analysis method was further applied to study corneal penetration using an ex vivo porcine whole-eye model.

Results: For dermal penetration, oily solutions, oily suspensions and nanosuspensions exhibited the least penetration, whereas liposomes and cyclodextrins showed enhanced penetration. Corneal curcumin penetration correlated with dermal penetration, with curcumin loaded into cyclodextrins penetrating the deepest.

Conclusions: Overall, our study suggests that the image analysis method previously developed for ex vivo skin penetration can easily be repurposed to study corneal penetration of hydrophobic drugs.

Citing Articles

Microneedle-Assisted Delivery of Curcumin: Evaluating the Effects of Needle Length and Formulation.

Chaiprateep E, Sengupta S, Keck C Micromachines (Basel). 2025; 16(2).

PMID: 40047600 PMC: 11857367. DOI: 10.3390/mi16020155.


Curcumin in Ophthalmology: Mechanisms, Challenges, and Emerging Opportunities.

Ribeiro A, Oliveira D, Cabral-Marques H Molecules. 2025; 30(3).

PMID: 39942561 PMC: 11820683. DOI: 10.3390/molecules30030457.


Extracellular Vesicles and PlantCrystals for Improved Bioavailability of Curcumin as a BCS Class IV Drug.

Alkhaldi M, Sehra T, Sengupta S, Keck C Molecules. 2025; 29(24.

PMID: 39770015 PMC: 11677860. DOI: 10.3390/molecules29245926.

References
1.
Rueden C, Schindelin J, Hiner M, DeZonia B, Walter A, Arena E . ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics. 2017; 18(1):529. PMC: 5708080. DOI: 10.1186/s12859-017-1934-z. View

2.
Achouri D, Alhanout K, Piccerelle P, Andrieu V . Recent advances in ocular drug delivery. Drug Dev Ind Pharm. 2012; 39(11):1599-617. DOI: 10.3109/03639045.2012.736515. View

3.
Srinivas S . Dynamic regulation of barrier integrity of the corneal endothelium. Optom Vis Sci. 2010; 87(4):E239-54. PMC: 2868144. DOI: 10.1097/OPX.0b013e3181d39464. View

4.
Prausnitz M, Noonan J . Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1999; 87(12):1479-88. DOI: 10.1021/js9802594. View

5.
Lorenzo-Veiga B, Sigurdsson H, Loftsson T, Alvarez-Lorenzo C . Cyclodextrin⁻Amphiphilic Copolymer Supramolecular Assemblies for the Ocular Delivery of Natamycin. Nanomaterials (Basel). 2019; 9(5). PMC: 6566826. DOI: 10.3390/nano9050745. View